Evaluation of Occlusal Force and Masticatory Function in Children With Molar-Incisor Hypomineralization

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age7-13
SponsorMarmara University

About this trial

This study aims to evaluate right-left chewing balance and masticatory function in children with Molar-Incisor Hypomineralization (MIH) before and after restorative treatment. MIH is a developmental enamel defect that may cause tooth sensitivity, discomfort during chewing, and functional asymmetry.

Children aged 7 to 12 years with bilateral MIH affecting the first permanent molars will receive glass hybrid restorative treatment. Right-left occlusal force distribution will be assessed using a digital occlusal analysis system. In addition, chewing side preference and chewing balance will be evaluated using a standardized chewing gum protocol. These two assessment methods will be used together to provide complementary information about masticatory function.

Measurements will be performed before treatment and during follow-up visits after treatment. The findings obtained from children with MIH will also be compared with healthy children without MIH. The study aims to determine whether restorative treatment improves chewing balance and functional oral performance in children with MIH.

Eligibility criteria

Qualifiers

Children aged 7 to 12 years

Presence of bilateral molar-incisor hypomineralization (MIH) affecting first permanent molars

Need for restorative treatment in MIH-affected molars

Cooperative children with sufficient cognitive ability to complete functional assessments

Disqualifiers

Temporomandibular disorders or orofacial pain

Systemic diseases or regular medication use affecting mastication

History of orthodontic treatment or parafunctional habits

Craniofacial anomalies or developmental dental anomalies

Trial design

Treatments tested in this trial

  • Glass Hybrid Restorative Treatment

Treatment groups

68 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators